Find uplifting stories about heroes, innovations, and solutions
155 results for "eli lilly"
Pharmaceutical giant Eli Lilly just switched on the biggest AI supercomputer in the industry, built with NVIDIA to speed up drug discovery. The massive computing power could help scientists create life-saving medications faster than ever before.
Pharmaceutical giant Eli Lilly is ramping up its efforts to develop gene therapies that could restore hearing in people with genetic hearing loss. The move signals growing confidence in cutting-edge treatments that address the root causes of deafness.
Eli Lilly is building a $3.5 billion manufacturing facility in Pennsylvania to produce breakthrough obesity treatments, including an experimental drug showing record-breaking weight loss results. The plant will create 850 permanent jobs and 2,000 construction positions when it opens in 2031.
Pharmaceutical giant Eli Lilly just invested up to $2.75 billion in AI-powered drug discovery that could revolutionize how we treat diseases. The partnership with biotech company Insilico Medicine marks one of the largest deals ever for medicines designed entirely by artificial intelligence.
Millions of Americans could soon afford life-changing obesity medications as drugmaker Eli Lilly slashes prices by more than half through a new employer program. The move addresses one of healthcare's biggest cost barriers while giving companies more control over benefits.
Hong Kong-based Insilico Medicine just landed a potential $2.75 billion partnership with pharmaceutical giant Eli Lilly, marking one of the largest AI drug development deals ever. The agreement shows how artificial intelligence is transforming medicine from science fiction into life-saving reality.
Eli Lilly just made its weight loss drug Zepbound more affordable for millions of workers by letting employers chip in on the cost. Instead of charging insurance prices, they're offering it at $449 a month with flexible employer subsidies.
Pharmaceutical giant Eli Lilly achieved positive results in nearly all its 2025 clinical trials, bringing new treatments for obesity, diabetes, and cancer closer to patients who need them. The company is also building the world's largest pharmaceutical AI supercomputer to speed up future drug discoveries.
Eli Lilly's experimental obesity medication helped patients lose an average of 28% of their body weight in a major trial, matching results typically seen only with bariatric surgery. The breakthrough treatment offers new hope for millions struggling with obesity, though researchers are working to reduce side effects.
AI drug developer Insilico Medicine just landed a massive partnership with pharma giant Eli Lilly worth up to $2.75 billion. The deal could accelerate how new medicines reach patients who need them.
A new diabetes treatment from Eli Lilly helped patients lose 15% of their body weight while improving blood sugar control, potentially becoming the most effective weight loss diabetes drug yet. The results offer hope for millions who struggle to shed pounds while managing their condition.
Millions of Americans struggling with obesity now have a new option: the FDA just approved Foundayo, the first oral tablet in a groundbreaking class of weight-loss medications. This pill could transform treatment by offering an easier alternative to weekly injections.
Eli Lilly's new obesity medication helped people with diabetes achieve significant weight loss and better blood sugar control, a notoriously difficult combination to achieve. While researchers are monitoring some cardiac events, the drug represents a major step forward for millions struggling with both conditions.
A one-time gene-editing treatment slashed bad cholesterol by 62% in early human trials, offering hope for millions who struggle with heart disease prevention. Eli Lilly's breakthrough therapy showed no serious side effects in the study.
A revolutionary gene-editing treatment from Eli Lilly can slash bad cholesterol by up to 62% with just one dose, and the effects last for years. The breakthrough could transform how we prevent heart disease, America's leading killer.
Pittsburgh Steelers fans erupted when they selected Naval Academy running back Eli Heidenreich in the final round of the 2026 NFL Draft. The hometown hero emerged in his dress blues, saluted the crowd, and earned a hero's welcome before deferring his Marine Corps service to chase his football dream.
In his first-ever World Cup match, New Zealand's Eli Just scored twice against Iran at a packed SoFi Stadium, leading his team to their best performance in tournament history. The All Whites drew 2-2 but showed the world they belong on football's biggest stage.
More than 10 million Americans just regained insurance coverage for a life-changing obesity treatment after CVS reversed its restrictions on Zepbound. The win came after drugmaker Eli Lilly slashed prices to make the medication more accessible.
Millions seeking weight loss solutions can now access a daily pill instead of weekly injections. The FDA approved Eli Lilly's Foundayo, making treatment easier and more accessible for people nationwide.
The FDA just approved a new obesity pill that's easier to take than any competitor, and it hit pharmacy shelves in record-breaking time. Patients now have more options than ever to manage their weight without needles. #
Showing 20 of 155